Mijugković Mirjana, Stanojević Ivan, Milović Novak, Cerović Snezana, Petrović Dejan, Jovanović Dragan, Aleksić Predrag, Kovacević Bozidar, Andjelić Tamara, Terzic Brankica, Djukić Mirjana, Vojvodić Danilo
Vojnosanit Pregl. 2016 Mar;73(3):266-72. doi: 10.2298/vsp150124006m.
BACKGROUND/AIM: Kidney injury molecule-1 (KIM-1) and aquaporin-1 (AQP-1) are potential early urinary biomarkers of clear renal cell carcinoma (cRCC). The aim of this study was to ascertain relationship between the urine concentrations KIM-1 and AQP-1 with tumor size, grade, pT stage and type of operation (radical or partial nephrectomy) in patients with cRCC.
Urinary concentrations of urinary KIM-1 (uKIM-1) and urinary AQP-1 (uAQP-1) were determined by commercially available ELISA kits. The analysis included 40 patients undergoing partial or radical nephrectomy for cRCC and 40 age- and sex-matched healthy adult volunteers.
The median preoperative concentrations of KIM-1 in the cRCC group [0.724 ? 1.120 ng/mg urinary creatinine (Ucr)] were significantly greater compared with controls (healthy volunteers) (0.210 +/- 0.082 ng/mgUcr) (p = 0.0227). Postoperatively, uKIM-1 concentration decreased significantly to control values (0.177 +/- 0.099 ng/mgUcr vs 0.210 + 0.082 ng/mgUcr, respectively). The size, grade and stage of tumor were correlated positively with preoperative uKIM-1 concentrations. Contrary to these results, concentrations of uAQP-1 in the cRCC group were significantly lower (0.111 +/- 0.092 ng/mgUcr) compared with the control group (0.202 +/- 0.078 ng/mgUcr) (p = 0.0014). Postoperatively, the concentrations of uAQP-1 increased progressively up to control values, approximately. We find no significant correlation between preoperative uAQP-1 concentrations and tumor size, grade and stage.
uKIM-1 was found to be a reliable diagnostic marker of cRCC, based on its significantly increased values before and decreased values after the nephrectomy.
背景/目的:肾损伤分子-1(KIM-1)和水通道蛋白-1(AQP-1)是肾透明细胞癌(cRCC)潜在的早期尿液生物标志物。本研究旨在确定cRCC患者尿液中KIM-1和AQP-1浓度与肿瘤大小、分级、pT分期及手术类型(根治性或部分肾切除术)之间的关系。
采用市售ELISA试剂盒测定尿KIM-1(uKIM-1)和尿AQP-1(uAQP-1)的浓度。分析纳入40例行cRCC部分或根治性肾切除术的患者以及40名年龄和性别匹配的健康成年志愿者。
cRCC组术前KIM-1的中位浓度[0.724±1.120 ng/mg尿肌酐(Ucr)]显著高于对照组(健康志愿者)(0.210±0.082 ng/mgUcr)(p = 0.0227)。术后,uKIM-1浓度显著下降至对照值(分别为0.177±0.099 ng/mgUcr和0.210 + 0.082 ng/mgUcr)。肿瘤的大小、分级和分期与术前uKIM-1浓度呈正相关。与这些结果相反,cRCC组uAQP-1的浓度显著低于对照组(0.202±0.078 ng/mgUcr)(0.111±0.092 ng/mgUcr)(p = 0.0014)。术后,uAQP-1的浓度逐渐升高至对照值左右。我们发现术前uAQP-1浓度与肿瘤大小、分级和分期之间无显著相关性。
基于肾切除术前uKIM-1值显著升高及术后降低,发现uKIM-1是cRCC可靠的诊断标志物。